Hidekazu Tanaka

Hidekazu Tanaka

Auto-generated profile, based on publicly available information

Hidekazu Tanaka

Pharmacology Laboratory, Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, 1-1-1 Noji-Higashi, Kusatsu, Shiga 525-8577, Japan

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2013 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
AOAkira Oda
Akira Oda
KYKanato Yamagata
Kanato Yamagata
SNSaya Nakagomi
Saya Nakagomi
HUHiroshi Uejima
Hiroshi Uejima
PWPattama Wiriyasermkul
Pattama Wiriyasermkul
HTHidekazu Tanaka
Hidekazu Tanaka

1 April 2020 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
KOKei Ozawa
Kei Ozawa
DMDaichi Mori
Daichi Mori
AHAyumu Hatanaka
Ayumu Hatanaka
TSToshinori Sawano
Toshinori Sawano
JNJin Nakatani
Jin Nakatani
HTHidekazu Tanaka
Hidekazu Tanaka
Qing Dai/Indigo Naturalis (QD) has been shown to ameliorate ulcerative colitis (UC) in clinical trials; however, its mechanism remains elusive. This study investigates the effects of QD on murine dextran sulfate sodium salt-induced colitis. Oral administration of QD protected the animals from colitis as manifested by weight loss, diarrhea, and rectal bleeding. QD was distinguishingly more effective than 5-aminosalicylate. Focused microarray analysis of genes expressed in the distal colon suggested that QD influences the inflammatory pathway. Anti-inflammatory activity of QD was confirmed by the suppression of nitric oxide (NO) production in response to interleukin-1β in cultured hepatocytes. Some of the constituents in QD, such as tryptanthrin (TRYP) and indigo, suppressed NO production. TRYP maintained body weight but did not inhibit bleeding. Indigo, on the other hand, partially ameliorated bleeding, but did not maintain body weight. The combination of TRYP and indigo did not show additive ameliorating activity. The methanol extract of QD showed an anti-colitis activity like that of TRYP. In contrast, the methanol-insoluble QD fraction moderately ameliorated diarrhea and bleeding. Combining these two fractions resulted in full anti-colitis activity. Further clarification of the active constituents will help in the discovery of a safe and potent prescription for UC.

1 January 1991 in The Japanese Journal of Physiology
Verified
Journal Article
Open access
PDF file
HTHidekazu Tanaka
Hidekazu Tanaka
ITIkuo Taniguchi
Ikuo Taniguchi
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 January 2014 in Neural Regeneration Research
Verified
Journal Article
Open access
HTHidekazu Tanaka
Hidekazu Tanaka
AOAkira Oda
Akira Oda
The cholinergic system is involved in a broad spectrum of brain function, and its failure has been implicated in Alzheimer's disease. Acetylcholine transduces signals through muscarinic and nicotinic acetylcholine receptors, both of which influence synaptic plasticity and cognition. However, the mechanisms that relate the rapid gating of nicotinic acetylcholine receptors to persistent changes in brain function have remained elusive. Recent evidence indicates that nicotinic acetylcholine receptors activities affect synaptic morphology and density, which result in persistent rearrangements of neural connectivity. Further investigations of the relationships between nicotinic acetylcholine receptors and rearrangements of neural circuitry in the central nervous system may help understand the pathogenesis of Alzheimer's disease.

1 September 2021 in Brain Research
Verified
Journal Article
Closed access
NYNatsumi Yamaguchi
Natsumi Yamaguchi
TSToshinori Sawano
Toshinori Sawano
KFKae Fukumoto
Kae Fukumoto
JNJin Nakatani
Jin Nakatani
SIShota Inoue
Shota Inoue
HTHidekazu Tanaka
Hidekazu Tanaka

25 February 2005 in ORL
Verified
Journal Article
Closed access
TITetsuya Ikeda
Tetsuya Ikeda
TKTakeo Kanaya
Takeo Kanaya
AMAkifumi Matsuda
Akifumi Matsuda
KMKenichi Motohashi
Kenichi Motohashi
HTHidekazu Tanaka
Hidekazu Tanaka
MHMakoto Hasegawa
Makoto Hasegawa
Non-Hodgkin lymphomas of the sinonasal region have been the subject of numerous studies. Previous reports have suggested that nasal lymphomas occurring in Orientals are mostly of the natural killer cell (NK)/T-cell phenotype which contrasts with the preponderance of the B-cell type in western populations. Recent studies indicated that NK/T-cell lymphoma constitutes the clinical condition of lethal midline granuloma. These reports led us to question whether all NK/T lymphomas are always lethal midline granuloma. We have investigated a series of 15 cases of non-Hodgkin lymphomas in the nasal and/or paranasal sinuses clinically, immunohistochemically and for the presence of Epstein-Barr virus (EBV). This study showed that the presence of EBV was common in nasal NK/T lymphoma, and this type of lymphoma was clearly highly frequent in other types of nasal lymphoma in our department. Moreover, in 4 cases of NK/T-cell lymphomas, the clinical features of lethal midline granuloma did not appear, indicating that NK/T lymphomas are not always lethal midline granuloma.